Device manufacturer, as written on reports
Biotronik And: medical device reports filed with FDA
3,418 reports name it as the manufacturer of the device involved, 2004–2009.
- 3,418
- reports naming it as manufacturer
- 0% of all MAUDE reports
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 20.7%
- classified as malfunction
- 62.3% across all reports
- 2.5%
- classified as death, as reported
- 0.9% across all reports
3,418 medical device reports received by FDA give Biotronik And as the manufacturer of the device involved, 0% of the MAUDE database, from November 2004 to August 2009. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (68.5%), malfunction (20.7%) and other (7.4%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| Dextrus 4136 | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 654 | 0 | 0.8% |
| Dextrus 4135 | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 370 | 0 | 0.5% |
| Setrox S 53 | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 213 | 128 | 1.2% |
| Dextrus 4137 | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 208 | 0 | 1% |
| Setrox S 45 | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 165 | 35 | 1.3% |
| Linox SD 65/16 | Permanent defibrillator electrodes | 130 | 31 | 1.2% |
| Linox SD 65/18 | Permanent defibrillator electrodes | 64 | 24 | 1.1% |
| Selox ST 53 | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 56 | 16 | 0.7% |
| Selox St 60 | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 45 | 6 | 0.6% |
| Lumax 340 Vr-T | Implantable cardioverter defibrillator (non-crt) | 42 | 0 | 5.2% |
| Lumax 340 Hf-T | Defibrillator, implantable, dual-chamber | 40 | 0 | 9.7% |
| Setrox S 60 | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 40 | 43 | 0.6% |
| Selox Jt 45 | Drug eluting permanent right ventricular (rv) or right atrial (ra) pacemaker electrodes | 32 | 12 | 0.7% |
| Linox S 65 | Permanent defibrillator electrodes | 19 | 25 | 0.6% |
| Linox Td 65/16 | Permanent defibrillator electrodes | 16 | 8 | 0.6% |
| Linox Td 65/18 | Permanent defibrillator electrodes | 12 | 5 | 0.6% |
| Belos Vr | Implantable cardioverter defibrillator (non-crt) | 5 | 0 | 0.5% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
| Product code | Device type | Reports | Share |
|---|---|---|---|
| DTB | Permanent pacemaker electrode | 2,124 | 62.1% |
| LWS | Implantable cardioverter defibrillator (non-crt) | 667 | 19.5% |
| DXY | Implantable pacemaker pulse-generator | 405 | 11.8% |
| MRM | Defibrillator, implantable, dual-chamber | 151 | 4.4% |
| NKE | Pulse generator, pacemaker, implantable, with cardiac resynchronization (crt-p) | 23 | 0.7% |
| NVZ | Pulse generator, permanent, implantable | 10 | 0.3% |
| DQX | Wire, guide, catheter | 9 | 0.3% |
| NIK | Defibrillator, automatic implantable cardioverter, with cardiac resynchronization (crt-d) | 9 | 0.3% |
| DTE | Pulse-generator, pacemaker, external | 5 | 0.1% |
| KRG | Programmer, pacemaker | 5 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about Biotronik And reports
How many FDA device reports name Biotronik And as manufacturer?
3,418 reports through August 2026, 0 of them in the latest 12 months.
Which of its brands appear most often?
Dextrus 4136 (654), Dextrus 4135 (370), Setrox S 53 (213), Dextrus 4137 (208) and Setrox S 45 (165).
Which device types does it report on?
permanent pacemaker electrode (62.1%), implantable cardioverter defibrillator (non-crt) (19.5%), implantable pacemaker pulse-generator (11.8%) and defibrillator, implantable, dual-chamber (4.4%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.